Chronic liver failure
ICD-10 K72.1 · ICD-11 DB99.8

What to Do When First-Line Therapy Fails to Control Acute Variceal Bleeding in Cirrhosis with Portal Hypertension

This protocol addresses acute upper gastrointestinal bleeding from variceal haemorrhage in patients with cirrhosis and portal hypertension — specifically the situation where the initial treatment approach has not achieved haemostasis.

Acute variceal haemorrhage must be suspected in any cirrhotic patient presenting with upper acute GI bleeding, and rescue management is required when the first line of care does not control it.

First-Line Therapy and Its Failure Condition

Initial management of acute variceal haemorrhage includes volume replacement, vasoactive drug therapy (terlipressin, somatostatin, or octreotide), antibiotic prophylaxis, pre-endoscopy erythromycin, and endoscopic variceal band ligation within the first 12 hours.

This rescue protocol is indicated when those measures fail to achieve their primary goals: control of bleeding and haemoglobin maintained within the target range.

Rescue Approach

When first-line therapy does not control bleeding, a structured rescue intervention is indicated — involving an interventional procedure used as the rescue therapy of choice, alongside a temporary bridging option to stabilise the patient.

The complete sequenced protocol, including the specific interventions, decision criteria, and bridging considerations, is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jhep.2018.03.024

Acute variceal haemorrhage (AVH) must be suspected in any cirrhotic patient presenting with upper acute GI bleeding and treatment should be started as soon as bleeding is clinically confirmed, regardless the lack of confirmation by upper endoscopy.

TIPS should be used as the rescue therapy of choice in such cases (I;1).

Balloon tamponade should be used in case of uncontrolled bleeding, but with pre-requisite of expertise and as a temporary "bridge" until definitive treatment can be instituted and for a maximum of 24 h (III;1). Removable, covered and self-expanding oesophageal stents can be used as alternative to balloon tamponade (I;2).

View source ↗